Short, stereoselective synthesis of the naturally occurring pyrrolidine radicamine B and a formal synthesis of nectrisine

Journal of Organic Chemistry

Volumn 73, Issue 19, 2008, Pages 7779-7782

  Ribes, Celia ^a   Falomir, Eva ^a   Carda, Miguel ^a   Marco, J Alberto ^b  

^a UNIVERSITAT JAUME I   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; AMINO ACIDS; CHEMICAL REACTIONS; ORGANIC COMPOUNDS; STEREOCHEMISTRY; STEREOSELECTIVITY;

CHEMICAL EQUATIONS; D-SERINE; FORMAL SYNTHESIS; GLUCOSIDASE; ONE-POT; PYRROLIDINE; STARTING MATERIALS; STEREO-SELECTIVE SYNTHESIS;

SYNTHESIS (CHEMICAL);

ALDEHYDE; ALPHA GLUCOSIDASE INHIBITOR; NECTRISINE; PYRROLIDINE DERIVATIVE; RADICAMINE B; SERINE; UNCLASSIFIED DRUG;

ARTICLE; CHIRALITY; DRUG SYNTHESIS; STEREOCHEMISTRY;

ALDEHYDES; IMINO FURANOSES; PYRROLIDINES; SERINE; STEREOISOMERISM;

EID: 53049084856     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo8012989     Document Type: Article

References (79)

1. (a) Plunkett, A. O. Nat. Prod. Rep. 1994, 11, 581-590.
2. (b) O'Hagan, D. Nat. Prod. Rep. 1997, 14, 637-651.
3. (c) O'Hagan, D. Nat. Prod. Rep. 2000, 17, 435-446.
4. (d) Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Phytochemistry 2001, 56, 265-295.
5. (a) Evans, S. V.; Fellows, L. E.; Shing, T. K. M.; Fleet, G. W. J. Phytochemistry 1985, 24, 1953-1955.
6. (b) Molyneux, R. J.; Pan, Y. T.; Tropea, J. E.; Elbein, A. D.; Lawyer, C. H.; Hughes, D. J.; Fleet, G. W. J. J. Nat. Prod. 1993, 56, 1356-1364.
7. (c) Tsuchiya, K.; Kobayashi, S.; Kurokawa, T.; Nakagawa, T.; Shimada, N. J. Antibiot. 1995, 48, 630-634.
8. (d) Asano, N. Curr. Top. Med. Chem. 2003, 3, 471-484.
9. (e) Greimel, P.; Spreitz, J.; Stütz, A. E.; Wrodnigg, T. M. Curr. Top. Med. Chem. 2003, 3, 513-523.
10. (f) Compain, P.; Martin, O. R. Curr. Top. Med. Chem. 2003, 3, 541-560.
11. (g) Butters, T. D.; Dwek, R. A.; Platt, F. M. Curr. Top. Med. Chem. 2003, 3, 561-574.
12. (a) Shibano, M.; Tsukamoto, D.; Masuda, A.; Tanaka, Y.; Kusano, G. Chem. Pharm. Bull. 2001, 49, 1362-1365.
13. (b) Shibano, M.; Tsukamoto, D.; Kusano, G. Heterocycles 2002, 57, 1539-1553.
14. (a) Ganem, B. Acc. Chem. Res. 1996, 29, 340-347.
15. (b) Compain, P.; Martin, O. R. Bioorg. Med. Chem. 2001, 9, 3077-3092.
16. (c) Asano, N. Glycobiology 2003, 13, 93R-104R.
17. (a) Shibata, T.; Nakayama, O.; Tsurumi, Y.; Okuhara, M.; Terano, H.; Kohsaka, M. J. Antibiot. 1988, 41, 296-301.
18. (b) Tsujii, E.; Muroi, M.; Shiragami, N.; Takatsuki, A. Biochem. Biophys. Res. Commun. 1996, 220, 459-466.
19. (a) Look, G. C.; Fotsch, C. H.; Wong, C. H. Acc. Chem. Res. 1993, 26, 182-190.
20. (b) Pichon, M.; Figadère, B. Tetrahedron: Asymmetry 1996, 7, 927-964.
21. (c) Enders, D.; Thiebes, C. Pure Appl. Chem. 2001, 73, 573-578.
22. (d) Yoda, H. Curr. Org. Chem. 2002, 6, 223-243.
23. (e) Cipolla, L.; La Ferla, B.; Nicotra, F. Curr. Top. Med. Chem. 2003, 3, 485-511.
24. (f) El-Ashry, E. H.; El-Nemr, A. Carbohydr. Res. 2003, 338, 2265-2290.
25. (g) Pyne, S. G.; Davis, A. S.; Gates, N. J.; Hartley, J. P.; Lindsay, K. B.; Machan, T.; Tang, M. Synlett 2004, 2670-2680.
26. (h) Popowycz, F.; Gerber-Lemaire, S.; Schütz, C.; Vogel, P. Helv. Chim. Acta 2004, 87, 800-810.
27. (i) Cren, S.; Gurcha, S. S.; Blake, A. J.; Besra, G. S.; Thomas, N. R. Org. Biomol. Chem. 2004, 2, 2418-2420.
28. (j) Ayad, T.; Genisson, Y.; Baltas, M. Curr. Org. Chem. 2004, 8, 1211-1233.
29. (k) Izquierdo, I.; Plaza, M. T.; Rodríguez, M.; Franco, F.; Martos, A. Tetrahedron 2005, 61, 11697-11704.
30. (l) Brinner, K. M.; Ellman, J. A. Org. Biomol. Chem. 2005, 3, 2109-2113.
31. (m) Huang, P.-Q. Synlett 2006, 1133-1149.
32. (n) Bellina, F.; Rossi, R. Tetrahedron 2006, 62, 7213-7256.
33. (o) Pandey, G.; Banerjee, P.; Gadre, S. R. Chem. Rev. 2006, 106, 4484-4517.
34. (p) Murruzzu, C.; Riera, A. Tetrahedron: Asymmetry 2007, 18, 149-154.
35. (q) Håkansson, A. E.; van Ameijde, J.; Guglielmini, L.; Horne, G.; Nash, R. J.; Evinson, E. L.; Kato, A.; Fleet, G. W. J. Tetrahedron: Asymmetry 2007, 18, 282-289.
36. (r) Martin, O. Ann. Pharm. Fr. 2007, 65, 5-13.
37. (a) Chen, S.-H.; Danishefsky, S. J. Tetrahedron Lett. 1990, 31, 2229-2232.
38. (b) Kayakiri, H.; Nakamura, K.; Takase, S.; Setoi, H.; Uchida, I.; Terano, H.; Hashimoto, M.; Tada, T.; Koda, S. Chem. Pharm. Bull. 1991, 39, 2807-2812.
39. (c) Kogoshi, N.; Takatsuki, A.; Kim, Y. J.; Kitahara, T. Heterocycles 1998, 49, 63-66.
40. (d) Kim, Y. J.; Takatsuki, A.; Kogoshi, N.; Kitahara, T. Tetrahedron 1999, 55, 8353-8364.
41. (e) Bosco, M.; Bisseret, P.; Bouix-Peter, C.; Eustache, J. Tetrahedron Lett. 2001, 42, 7949-7952.
42. (f) Hulme, A. N.; Montgomery, C. H. Tetrahedron Lett. 2003, 44, 7649-7653.
43. (g) Merino, P.; Delso, I.; Tejero, T.; Cardona, F.; Marradi, M.; Faggi, E.; Parmeggiani, C.; Goti, A. Eur. J. Org. Chem. 2008, 2929-2947.
44. Analogues and surrogates of nectrisine with a similar pharmacological profile have also been prepared. See: (a) Tschamber, T.; Gessier, F.; Neuburger, M.; Gurcha, S. S.; Besra, G. S.; Streith, J. Eur. J. Org. Chem. 2003, 2792-2798.
45. (b) Tschamber, T.; Gessier, F.; Dubost, E.; Newsome, J.; Tarnus, C.; Kohler, J.; Neuburger, M.; Streith, J. Bioorg. Med. Chem. 2003, 11, 3559-3568.
46. (a) Yu, C.-Y.; Huang, M.-H. Org. Lett. 2006, 8, 3021-3024.
47. (b) Gurjar, M. K.; Borhade, R. G.; Puranik, V. G.; Ramana, C. V. Tetrahedron Lett. 2006, 47, 6979-6981.
48. (c) Merino, P.; Delso, I.; Tejero, T.; Cardona, F.; Goti, A. Synlett 2007, 2651-2654.
49. (d) Liu, C.; Gao, J.; Yang, G.; Wightman, R. H.; Jiang, S. Lett. Org. Chem. 2007, 4, 556-558.
50. Prepared from D-serine according to: Campbell, A. D.; Raynham, T. M.; Taylor, R. J. K. Synthesis 1998, 1707-1709.
51. For a review on Garner's aldehyde, see: Liang, X.; Andersch, J.; Bols, M. J. Chem. Soc., Perkin Trans. 1 2001, 2136-2157.
52. Dondoni, A.; Merino, P.; Perrone, D. Tetrahedron 1993, 49, 2939-2956. Our modification consisted in carrying out the dihydroxylation by means of the Sharpless asymmetric procedure. In this way, the overall yield of 5 from Garner's (R)-aldehyde was improved from ca. 50 to 83% (see Experimental Section).
53. For examples of O-benzylation with this method, see: (a) Mislow, K.; O'Brien, R. E.; Schaefer, H. J. Am. Chem. Soc. 1962, 84, 1940-1944.
54. (b) Takai, K.; Heathcock, C. H. J. Org. Chem. 1985, 50, 3247-3251.
55. (c) Marshall, J. A.; Seletsky, B. M.; Luke, G. P. J. Org. Chem. 1994, 59, 3413-3420.
56. (d) Chen, M.-D.; He, M.-Z.; Zhou, X.; Huang, L.-Q.; Ruan, Y.-P.; Huang, P.-Q. Tetrahedron 2005, 61, 1335-1344.
57. (e) Yokokawa, F.; Inaizumia, A.; Shioiri, T. Tetrahedron 2005, 61, 1459-1480.
58. For reviews on Weinreb amides, see: (a) Mentzel, M.; Hoffmann, H. M. R. J. Prakt. Chem. 1997, 339, 517-524.
59. (b) Singh, J.; Satyamurthi, N.; Aidhen, I. S. J. Prakt. Chem. 2000, 342, 340-347.
60. (c) Khlestkin, V. K.; Mazhukin, D. G. Curr. Org. Chem. 2003, 7, 967-993.
61. The conditions used for the preparation of Weinreb amide 8 were taken from: Williams, J. M.; Jobson, R. B.; Yasuda, N.; Marchesini, G.; Dolling, U. H.; Grabowski, E. J. J. Tetrahedron Lett. 1995, 36, 5461-5464.
62. Kamada, A.; Sasaki, A.; Kitazawa, N.; Okabe, T.; Nara, K.; Hamaoka, S.; Araki, S.; Hagiwara, H. Chem. Pharm. Bull 2004, 52, 79-88. The Grignard reagent has now become commercially available.
63. The stereochemical course of the reduction of 9 was assumed to be as depicted in Scheme 2 upon reliance on the results in the reduction of a ketone closely related to 9 (with an alkyl residue instead of the aryl group), where the configuration of the alcohol was secured by means of X-ray diffraction (unpublished results).
64. Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 3rd ed.; John Wiley and Sons: New York, 1999; pp 518-525.
65. For some recent examples of pyrrolidine ring closure via intramolecular nucleophilic displacement, see for example: (a) Yoda, H.; Asai, F.; Takabe, K. Synlett 2000, 1001-1003.
66. (b) Merino, P.; Franco, S.; Lafuente, D.; Merchán, F.; Revuelta, J.; Tejero, T. Eur. J. Org. Chem. 2003, 2877-2881.
67. (c) Chandrasekhar, S.; Chandrasekhar, G.; Vijeender, K.; Sarma, G. D. Tetrahedron: Asymmetry 2006, 17, 2864-2869.
68. This idea was suggested by the fact that acidic treatment of alcohol 10 under similar conditions as 4 (TFA, 1 h, 0°C) also gave a 2:1 mixture of pyrrolidines 11, together with extensive decomposition.
69. Shimizu, T.; Ohzeki, T.; Hiramoto, K.; Hori, N.; Nakata, T. Synthesis 1999, 1373-1385.
70. Ribes, C.; Falomir, E.; Murga, J. Tetrahedron 2006, 62, 1239-1244.
71. (a) Card, P. J.; Hitz, W. D. J. Org. Chem. 1985, 50, 891-893.
72. (b) Takayama, S.; Martin, R.; Wu, J.; Laslo, K.; Siuzdak, G.; Wong, C.-H. J. Am. Chem. Soc. 1997, 119, 8146-8151.
73. (c) Espelt, L.; Parella, T.; Bujons, J.; Solans, C.; Joglar, J.; Delgado, A.; Clapés, P. Chem. - Eur. J. 2003, 9, 4887-4899.
74. Mixtures of 2 and 13 (5-epi-radicamine B) of variable composition were obtained, with the undesired 13 being always the major compound.
75. For a synthesis of 13, see: Zhou, X.; Liu, W.-J.; Ye, J.-L.; Huang, P.-Q. Tetrahedron 2007, 63, 6346-6357.
76. Wong, C.-H.; Provencher, L.; Jung, S.-H.; Wang, Y.-F.; Chen, L.; Wang, R.; Steensma, D. H. J. Org. Chem. 1995, 60, 1492-1501.
77. For a similar situation, see for example: Yu, D.-S.; Xu, W.-X.; Liu, L.-X.; Huang, P.-Q. Synlett 2008, 1189-1192.
78. Hulme, A. N.; Montgomery, C. H.; Henderson, D. K. J. Chem. Soc., Perkin Trans. 1 2000, 1837-1841.
79. The syntheses reported in ref 7g, 9 involve reaction sequences of 9-11 steps from D-xylose, L-xylose, or L-arabinose as the starting materials. Overall yields were in the range from 8 to 17%.